Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patients.
Scheibenbogen
C
C
Hunstein
W
W
Keilholz
U
U
D000328:Adult; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D007376:Interleukin-2 / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged; D014820:Vitiligo / Q000209:etiology*
D016898:Interferon-alpha; D007376:Interleukin-2